CTA-PA
CTA-PA
EIDP, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $3.91B ▲ | $941M ▼ | $-544M ▼ | -13.91% ▼ | $0 ▲ | $862M ▲ |
| Q3-2025 | $2.62B ▼ | $1.08B ▼ | $-318M ▼ | -12.15% ▼ | $-0.47 ▼ | $-24M ▼ |
| Q2-2025 | $6.46B ▲ | $1.69B ▲ | $1.31B ▲ | 20.35% ▲ | $1.92 ▲ | $2.16B ▲ |
| Q1-2025 | $4.42B ▲ | $1.25B ▲ | $652M ▲ | 14.76% ▲ | $0.95 ▲ | $1.12B ▲ |
| Q4-2024 | $3.98B | $1.16B | $-41M | -1.03% | $-0.05 | $450M |
What's going well?
Sales surged nearly 50%, and the company swung to an operating profit after a loss last quarter. Gross margins improved, and expenses were kept in check relative to revenue growth.
What's concerning?
Despite better sales and operations, a massive non-operating loss wiped out all gains and led to a bigger net loss. The quality of earnings is poor due to these one-off or unusual charges.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $4.53B ▲ | $42.84B ▲ | $18.46B ▲ | $24.14B ▼ |
| Q3-2025 | $2.81B ▲ | $42.2B ▲ | $17.09B ▲ | $25.11B ▼ |
| Q2-2025 | $2.14B ▲ | $41.76B ▼ | $15.61B ▼ | $25.91B ▲ |
| Q1-2025 | $2.01B ▼ | $42.12B ▲ | $17.6B ▲ | $24.29B ▲ |
| Q4-2024 | $3.48B | $40.83B | $16.8B | $23.79B |
What's financially strong about this company?
The company paid down a lot of debt and boosted its cash reserves, giving it a solid safety net. Customer prepayments are up sharply, showing strong demand and upfront cash flow.
What are the financial risks or weaknesses?
Retained earnings swung negative, suggesting a loss or heavy payout, and equity declined. The company also relies heavily on goodwill and intangible assets, which could be risky if acquisitions disappoint.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-537M ▼ | $4.38B ▲ | $-188M ▼ | $-2.2B ▼ | $1.99B ▲ | $4.15B ▲ |
| Q3-2025 | $-308M ▼ | $193M ▼ | $-157M ▲ | $367M ▲ | $420M ▲ | $36M ▼ |
| Q2-2025 | $1.38B ▲ | $947M ▲ | $-164M ▼ | $-808M ▼ | $22M ▲ | $829M ▲ |
| Q1-2025 | $667M ▲ | $-2.11B ▼ | $-34M ▼ | $995M ▲ | $-1.13B ▼ | $-2.2B ▼ |
| Q4-2024 | $-48M | $5.32B | $238M | $-4.84B | $666M | $5.14B |
What's strong about this company's cash flow?
The company generated a huge amount of cash from operations, paid down debt, and increased its cash balance. Cash flow quality is high, with real cash coming in, not just accounting profits.
What are the cash flow concerns?
The big cash surge was mostly due to a one-time boost from working capital changes, which may not repeat. Net losses are growing, and receivables are rising, which could hurt future cash flow.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Crop Protection | $860.00M ▲ | $990.00M ▲ | $810.00M ▼ | $1.06Bn ▲ |
Seed | $2.07Bn ▲ | $2.96Bn ▲ | $590.00M ▼ | $1.39Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Seed | $2.07Bn ▲ | $2.96Bn ▲ | $590.00M ▼ | $1.39Bn ▲ |
5-Year Trend Analysis
A comprehensive look at EIDP, Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a stable revenue base in a large, essential industry; a solid balance sheet with meaningful net cash and strong equity; and a sharply improved cash flow profile with robust free cash generation. The company also shows a clear commitment to innovation via steadily rising R&D and maintains consistent capital discipline in its investment spending. These factors collectively provide resilience and flexibility across economic and agricultural cycles.
Main risks center on margin compression, volatile profitability, and increasingly tight liquidity metrics. Operating margins and EBITDA have deteriorated even as net income has recently improved, raising questions about the quality and sustainability of earnings. Rising short‑term liabilities and declining liquidity ratios point to a thinner cushion against shocks, despite high cash balances. Negative retained earnings highlight that cumulative profitability after payouts has been weak. Competitive and regulatory pressures in agricultural inputs further increase uncertainty around pricing power and long‑term returns on R&D.
The overall picture is of a mature, strategically important business that is financially solid today and generating strong cash flow, but facing real operational and competitive challenges. If the company can translate its R&D investment into successful new products while stabilizing margins and keeping working capital under control, it may sustain or modestly improve its position over time. Conversely, if cost pressures and competitive intensity persist without sufficient product renewal, profitability and balance sheet quality could gradually erode. The outlook is therefore balanced, with meaningful upside and downside depending on execution and external conditions.
About EIDP, Inc.
https://www.corteva.comEIDP, Inc. engages in developing and supplying commercial seed and crop protection products for the agriculture industry in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates through two segments: Seed and Crop Protection.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $3.91B ▲ | $941M ▼ | $-544M ▼ | -13.91% ▼ | $0 ▲ | $862M ▲ |
| Q3-2025 | $2.62B ▼ | $1.08B ▼ | $-318M ▼ | -12.15% ▼ | $-0.47 ▼ | $-24M ▼ |
| Q2-2025 | $6.46B ▲ | $1.69B ▲ | $1.31B ▲ | 20.35% ▲ | $1.92 ▲ | $2.16B ▲ |
| Q1-2025 | $4.42B ▲ | $1.25B ▲ | $652M ▲ | 14.76% ▲ | $0.95 ▲ | $1.12B ▲ |
| Q4-2024 | $3.98B | $1.16B | $-41M | -1.03% | $-0.05 | $450M |
What's going well?
Sales surged nearly 50%, and the company swung to an operating profit after a loss last quarter. Gross margins improved, and expenses were kept in check relative to revenue growth.
What's concerning?
Despite better sales and operations, a massive non-operating loss wiped out all gains and led to a bigger net loss. The quality of earnings is poor due to these one-off or unusual charges.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $4.53B ▲ | $42.84B ▲ | $18.46B ▲ | $24.14B ▼ |
| Q3-2025 | $2.81B ▲ | $42.2B ▲ | $17.09B ▲ | $25.11B ▼ |
| Q2-2025 | $2.14B ▲ | $41.76B ▼ | $15.61B ▼ | $25.91B ▲ |
| Q1-2025 | $2.01B ▼ | $42.12B ▲ | $17.6B ▲ | $24.29B ▲ |
| Q4-2024 | $3.48B | $40.83B | $16.8B | $23.79B |
What's financially strong about this company?
The company paid down a lot of debt and boosted its cash reserves, giving it a solid safety net. Customer prepayments are up sharply, showing strong demand and upfront cash flow.
What are the financial risks or weaknesses?
Retained earnings swung negative, suggesting a loss or heavy payout, and equity declined. The company also relies heavily on goodwill and intangible assets, which could be risky if acquisitions disappoint.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-537M ▼ | $4.38B ▲ | $-188M ▼ | $-2.2B ▼ | $1.99B ▲ | $4.15B ▲ |
| Q3-2025 | $-308M ▼ | $193M ▼ | $-157M ▲ | $367M ▲ | $420M ▲ | $36M ▼ |
| Q2-2025 | $1.38B ▲ | $947M ▲ | $-164M ▼ | $-808M ▼ | $22M ▲ | $829M ▲ |
| Q1-2025 | $667M ▲ | $-2.11B ▼ | $-34M ▼ | $995M ▲ | $-1.13B ▼ | $-2.2B ▼ |
| Q4-2024 | $-48M | $5.32B | $238M | $-4.84B | $666M | $5.14B |
What's strong about this company's cash flow?
The company generated a huge amount of cash from operations, paid down debt, and increased its cash balance. Cash flow quality is high, with real cash coming in, not just accounting profits.
What are the cash flow concerns?
The big cash surge was mostly due to a one-time boost from working capital changes, which may not repeat. Net losses are growing, and receivables are rising, which could hurt future cash flow.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Crop Protection | $860.00M ▲ | $990.00M ▲ | $810.00M ▼ | $1.06Bn ▲ |
Seed | $2.07Bn ▲ | $2.96Bn ▲ | $590.00M ▼ | $1.39Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Seed | $2.07Bn ▲ | $2.96Bn ▲ | $590.00M ▼ | $1.39Bn ▲ |
5-Year Trend Analysis
A comprehensive look at EIDP, Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a stable revenue base in a large, essential industry; a solid balance sheet with meaningful net cash and strong equity; and a sharply improved cash flow profile with robust free cash generation. The company also shows a clear commitment to innovation via steadily rising R&D and maintains consistent capital discipline in its investment spending. These factors collectively provide resilience and flexibility across economic and agricultural cycles.
Main risks center on margin compression, volatile profitability, and increasingly tight liquidity metrics. Operating margins and EBITDA have deteriorated even as net income has recently improved, raising questions about the quality and sustainability of earnings. Rising short‑term liabilities and declining liquidity ratios point to a thinner cushion against shocks, despite high cash balances. Negative retained earnings highlight that cumulative profitability after payouts has been weak. Competitive and regulatory pressures in agricultural inputs further increase uncertainty around pricing power and long‑term returns on R&D.
The overall picture is of a mature, strategically important business that is financially solid today and generating strong cash flow, but facing real operational and competitive challenges. If the company can translate its R&D investment into successful new products while stabilizing margins and keeping working capital under control, it may sustain or modestly improve its position over time. Conversely, if cost pressures and competitive intensity persist without sufficient product renewal, profitability and balance sheet quality could gradually erode. The outlook is therefore balanced, with meaningful upside and downside depending on execution and external conditions.

CEO
Charles Victor Magro (Chem), MBA
Compensation Summary
(Year 2013)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 1 of 5
Ratings Snapshot
Rating : B+

